Tuesday, 20 Mar 2018

You are here

HERO Trial - Hydroxychloroquine Fails in Hand Osteoarthritis

UK researchers have treated 248 patients with moderate to severe hand pain and radiographic osteoarthritis (OA) and demonstrated no benefit after 12 months of hydroxychloroquine (HCQ), according to a recent article in Annals of Internal Medicine.

A randomized, double-blind, placebo-controlled clinical trial from 13 centers in England enrolled adults with hand OA and pain ≥4 (0-10 VAS) with evidence of radiographic hand osteoarthritis. The supposition was that control of inflammation and low grade synovitis would forestall the progression of OA. 

At 6 months (the primary endpoint), the mean hand pain was similar between groups (5.49 PBO vs 5.66 HCQ). No other significant treatment differences were found at 3, 6, or 12 months for any secondary outcomes.

Whlle X-rays and grayscale ultrasonography were done at baseline, these were not assessed at the endpoints. 

HCQ is one of many agents to have been tested, and failed at altering the course or symptom severity of hand OA.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Limited Utility of Arthroscopic Meniscal Surgery

JAMA Surgery reports that arthroscopic partial meniscectomy (APM) is still one of the most common surgeries performed, despite evidence from large trials (eg, FIDELITY study) showing that APM is no more effective than exercise and physical therapy, especially in adults over age 65 years.

Hip Replacement Augments Longevity

Data from Swedish hip replacement registry finds that total hip arthroplasty not only improves quality of life, it is also associated with increased life expectancy that lasts for 10 years after surgery, especially in primary osteoarthritis patients.

Teriparatide Superior to Risedronate in the VERO Trial

Lancet reports that in a study teriparatide with risedronate, post-menopausal women with severe osteoporosis had significantly fewer new vertebral and clinical fractures on teriparatide comared to those receiving risedronate.

This trial is one of the first to compare osteoporosis drugs with incident fractures as the primary outcome.

Two Types of Osteoarthritis Based on Cartilage Studies

A report from Annals of Rheumatic Diseases suggests that osteoarthritis (OA) may be two distinct diseases based on genetic studies of articular cartilage. (Citation source: https://buff.ly/2mNtUsL).

RNA sequencing of knee cartilage from 44 OA patients undergoing total knee replacement was compared to 6 additional patients with OA and 10 control patients with non-OA.

New Rise in Hip Fractures Amongst Women

Reuters reports that the incidence of hip fractures in older women in the U.S. is rising after more than a decade of decline, according to a large new study of Medicare recipients.